Clinical Trial Update: 89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma [NA]

View source ↗

Summary

This clinical trial update describes a study of 89Zr-bevacizumab PET imaging in relapsing multiple myeloma. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• 89Zr-bevacizumab (bevacizumab)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Multiple Myeloma | NA | Status: UNKNOWN